- Home
- NAUT vs ABSI Comparison
NAUT vs ABSI Comparison
Compare NAUT & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | ABSI |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 305.7M | 357.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAUT | ABSI |
|---|---|---|
| Price | $2.39 | $2.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $4.00 | ★ $7.98 |
| AVG Volume (30 Days) | 220.0K | ★ 2.5M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.07 | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $992.86 | $313.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.62 | $2.01 |
| 52 Week High | $3.08 | $5.23 |
Technical Indicators
Market Signals| Indicator | NAUT | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 44.69 |
| Support Level | $1.82 | $2.49 |
| Resistance Level | $3.08 | $2.88 |
| Average True Range (ATR) | 0.27 | 0.15 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 23.08 | 41.13 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.